
At a White House meeting with President Trump, CEO Mark Zuckerberg outlined Meta’s massive capital spending ambitions, far exceeding the already projected $66 - 72B in 2025 (a 68% jump from 2024)2. With “similarly significant” spending expected in 2026, the numbers could suggest an additional $300B+ earmarked for 2027–2028, perhaps underscoring Meta’s bet that AI and data infrastructure will be the backbone of future growth.3
![]()
NextEra Energy is advancing plans to reopen Iowa’s mothballed Duane Arnold nuclear plant (offline since 2020), aiming for it to go back online by late 2028, a move approved by the Federal Energy Regulatory Commission and fuelled by surging AI data centre demand4. Generating over 600 megawatts of carbon-free power, the plant is poised to meet tech giants’ appetite for reliable, zero-emissions energy.5
![]()
At the Munich Motor Show, BMW is set to unveil the iX3, its first “software-defined vehicle”, potentially marking a shift from traditional hardware toward centralised computer systems.7 Backed by more than €10 billion in software investment, the launch appears to mark BMW’s bid to compete with Tesla and fast-growing Chinese EV makers.8
![]()
Backed by the Chips Act, Apple’s $600B pledge leans on suppliers like TSMC and Broadcom to expand U.S. capacity, potentially strengthening Apple’s supply chain resilience amid growing trade tensions.10 Apple’s financial commitment represents one of the largest private sector investments in American manufacturing infrastructure in recent history.11
![]()
The U.S. Army has awarded prototype contracts to Anduril Industries (partnering with Meta Platforms, Qualcomm, and Gentex) and Rivet Industries to develop the next generation of battlefield headsets.13 Rivet’s award totals $195M, while Anduril secured $159M, building on the lessons of Microsoft’s earlier IVAS program, which struggled despite $1.36B in sunk costs.14 The rebranded effort, known as Soldier Borne Mission Command (SBMC), emphasises modularity, open architectures, and software-driven upgrades informed by 260,000+ hours of soldier testing.15 Meta’s involvement highlights Silicon Valley’s growing willingness to engage in defence work, following policy shifts allowing its AI tools in U.S. military projects.16
![]()
Eli Lilly’s oral weight-loss drug orforglipron cleared another Phase 3 trial, achieving its main goals and potentially set the stage for global regulatory submissions.18 In the ATTAIN-2 study, the once-daily GLP-1 pill delivered up to 10.5% weight loss over 72 weeks at the highest dose, alongside improvements in key diabetes markers like A1C.19 By comparison, Novo Nordisk’s investigational oral semaglutide led to 7.3% weight loss in a similar cohort of patients.20
![]()
1. Barrons.com (08/09/2025) Meta AI Spending Spree Set to Top $600 Billion Over 3 Years. Which Stocks Will Get a Boost
2. TechCrunch (30/07/2025) Meta to spend up to $72B on AI infrastructure in 2025 as compute arms race escalates
3. AI Magazine (08/04/2025) How Meta's $1bn AI Data Centre will Power Tech Innovation
4. CNBC (01/09/2025) An Iowa nuclear plant is the next contender to restart, spurred by AI data center demand
5. Ibid
6. MooMoo (03/09/2025) Betting on the "super brain," BMW is investing 10 billion euros to develop the Neue Klasse platform, challenging its Chinese electric vehicle competitors
7. Ibid
8. Ibid
9. FT.com (07/08/2025) What is Apple’s $600bn US investment pledge?
10. Ibid
11. Animal House (12/08/2025) Summarizing Apple’s $600 Billion Pledge to the U.S. Economy
12. Bloomberg (08/09/2025) US Army Awards Combat Goggle Contracts to Anduril-META Team, Rivet
13. Ibid
14. BreakingDefense.com (08/09/2025) Army taps Anduril-Meta team, plus new entrant Rivet, for IVAS recompete
15. AI Invest (08/09/2025) U.S. Army Awards Contracts to Anduril-Meta and Rivet for Next-Gen Combat Goggles Development
16. Ibid
17. Gene Online (07/08/2025) Eli Lilly Plans FDA Submission for Weight-Loss Pill Orforglipron by 2025
18. Ibid
19. Forbes (02/09/2025) Oral GLP-1 Pill For Weight Loss Shows Promise, But Challenges Remain
20. Ibid